Delivery Order SPE2DB20D9127-SPE2DB23FPRU9
- Not listed
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at eleven thousand four hundred thirty-four dollars and thirty cents ($11,434.30) to DMS Pharmaceutical Group Incorporated. The order is for four hundred fifty-six thousand two hundred thirty-five (456,235) vials of the pharmaceutical Velcade at three and a half (3.5) milligrams per vial. Performance will take place at DMS Pharmaceutical's facility...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-two thousand eight hundred sixty-eight dollars and sixty cents ($22,868.60) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the contract, DMS Pharmaceutical Group will provide four hundred fifty-six thousand two hundred thirty-three (456,233) units of 3.5 mg VELCADE vials to the Defense Logistics Agency in support of Department of Defense requirements. Performance will occur at the prime...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a delivery order valued at approximately $6,860 to DMS Pharmaceutical Group Inc. for VELCADE 3.5 MG VIALS. The firm fixed price contract has a period of performance from September 14, 2023 through October 5, 2023, with all work to be conducted by DMS Pharmaceutical at its facility located in Park Ridge, Illinois. No subcontractors or set aside designations were identified. The Defense...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $23,314.40 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,566,129,177 vials of the prescription drug Velcade (bortezomib) for the treatment of multiple myeloma and mantle cell lymphoma. This delivery order was placed under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract valued at $11,434.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4559578220 VELCADE 3.5 MG VIALS, with a completion date of January 26, 2023. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $23,314.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a period of performance through June 24, 2024, is for the supply of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,286.86 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562330077 VELCADE 3.5 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from September 15, 2023 through October 6, 2023. No subcontractors or set aside designations were identified. This delivery order was likely placed against DLA's Pharmaceutical Prime Vendor contract to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,758.60 delivery order is for the supply of VELCADE 3.5 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,744.20, is for the provision of Velcade 3.5 mg vials, with a period of performance ending on November 24, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order valued at $23,314.40, is for the supply of 4566144024 - VELCADE 3.5 MG VIALS. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPRU9Delivery Order
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at thirty-four thousand three hundred two dollars and ninety cents ($34,302.90) to DMS Pharmaceutical Group Incorporated. DMS will provide four hundred fifty-six thousand two hundred thirty-four thousand eighty-seven (4562345087) vials of the cancer drug Velcade (bortezomib) for injection to a military treatment facility located in Park Ridge, Illinois. The order has a period of performance starting September 26, 2023 and ending October 18, 2023 to fulfill a requirement for this chemotherapy medication in support of DLA's medical supply chain mission. No subcontractors or set-aside designations were identified in the award information.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 9/26/23 |